Načítá se...
Repurposing an anti‐cancer agent for the treatment of hypertrophic heart disease
Coronary microvascular dysfunction combined with maladaptive cardiomyocyte morphology and energetics is a major contributor to heart failure advancement. Thus, dually enhancing cardiac angiogenesis and targeting cardiomyocyte function to slow, or reverse, the development of heart failure is a logica...
Uloženo v:
| Vydáno v: | J Pathol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900130/ https://ncbi.nlm.nih.gov/pubmed/31424556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.5340 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|